Palisade Bio Inc (NASDAQ: PALI) on Friday, soared 16.20% from the previous trading day, before settling in for the closing price of $0.77. Within the past 52 weeks, PALI’s price has moved between $0.53 and $4.32.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 77.35%. The company achieved an average annual earnings per share of 83.10%. With a float of $9.10 million, this company’s outstanding shares have now reached $9.12 million.
Palisade Bio Inc (PALI) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Palisade Bio Inc is 0.24%, while institutional ownership is 6.18%.
Palisade Bio Inc (PALI) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -2.32 earnings per share (EPS) for the period topping the consensus outlook (set at -3.36) by 1.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 83.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.67% during the next five years compared to 77.35% growth over the previous five years of trading.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Palisade Bio Inc (PALI) is currently performing well based on its current performance indicators. A quick ratio of 1.55 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.16, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Compared to the last year’s volume of 1.12 million, its volume of 0.89 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 90.19%.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 26.88%, which indicates a significant decrease from 97.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0545 in the past 14 days, which was lower than the 0.0829 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7858, while its 200-day Moving Average is $0.9580. Nevertheless, the first resistance level for the watch stands at $0.9416 in the near term. At $0.9849, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.0622. If the price goes on to break the first support level at $0.8210, it is likely to go to the next support level at $0.7437. Now, if the price goes above the second support level, the third support stands at $0.7004.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
Market capitalization of the company is 8.19 million based on 9,119K outstanding shares. Right now, sales total 0 K and income totals -14,440 K. The company made 0 K in profit during its latest quarter, and -2,780 K in sales during its previous quarter.
